NCT00649324View on ClinicalTrials.gov

Fasting Study of Hydrochlorothiazide Tablets 50 mg to Hydrochlorothiazide Tablets 50 mg

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Healthy
Interventions
DRUG

Hydrochlorothiazide Tablets 50 mg

50mg, single dose fasting

DRUG

Hydrochlorothiazide Tablets (50 mg

50mg, single dose fasting

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00649324 - Fasting Study of Hydrochlorothiazide Tablets 50 mg to Hydrochlorothiazide Tablets 50 mg | Biotech Hunter | Biotech Hunter